This inventor holds 3 USPTO granted patents. Top assignees: Schering Aktiengesellschaft, Forschungszentrum Rossendorf E.v.. Active years: 2004-2010.
Company Filing History:
2 out of 1,409 
1 out of 11 Years Active: 2004-2010
Title: Bernd Johannsen: Innovator in Nuclear Medical Diagnostics
Introduction
Bernd Johannsen is a notable inventor based in Dresden, Germany. He has made significant contributions to the field of nuclear medical diagnostics and therapy. With a total of 3 patents, Johannsen's work focuses on innovative solutions that enhance medical practices.
Latest Patents
Johannsen's latest patents include groundbreaking inventions such as metal complexes based on tetrathiol ligands. These complexes are designed for use in nuclear medical diagnostics and endoradionuclide therapy. The patents provide methods for producing radiolytically and metabolically stable metal complexes that can be utilized in various medical applications. Another significant invention is related to radiopharmaceuticals for diagnosing Alzheimer's disease. This invention allows radiopharmaceuticals to pass through the blood-brain barrier and bind to the CCR1 receptor in brain tissue, offering new avenues for diagnosing Alzheimer's disease.
Career Highlights
Throughout his career, Johannsen has worked with prominent organizations, including Schering Aktiengesellschaft and Forschungszentrum Rossendorf e.V. His experience in these institutions has contributed to his expertise in the field of nuclear medicine.
Collaborations
Johannsen has collaborated with notable colleagues such as Harald Dinter and Peter Maeding. These partnerships have further enriched his research and development efforts.
Conclusion
Bernd Johannsen's innovative work in nuclear medical diagnostics and therapy showcases his dedication to advancing medical science. His patents and collaborations reflect a commitment to improving healthcare outcomes through technology.